News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Canakinumab Prevents Flares in Gout Patients, Robert Wood Johnson University Hospital Study



6/21/2010 7:16:20 AM

MedPage Today -- ROME -- Gout patients receiving treatment with standard allopurinol therapy appear to have a reduced risk of disease flares if they are treated with the investigative monoclonal antibody canakinumab, researchers said here.

Read at PharmaBiz
Read at MedPageToday


comments powered by Disqus
   
Gout

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES